We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+12.51%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.86B
AUM Growth
+$246M
Cap. Flow
+$82.5M
Cap. Flow %
4.43%
Top 10 Hldgs %
34.22%
Holding
1,158
New
69
Increased
498
Reduced
498
Closed
91

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$12.9M
2
MSFT icon
Microsoft
MSFT
+$12.5M
3
NVDA icon
NVIDIA
NVDA
+$7.63M
4
AMZN icon
Amazon
AMZN
+$5.14M
5
TSLA icon
Tesla
TSLA
+$4.94M

Top Sells

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$3.11M
2
XOM icon
ExxonMobil
XOM
+$2.53M
3
IMGN
Immunogen Inc
IMGN
+$2.22M
4
CVX icon
Chevron
CVX
+$2.06M
5
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$1.23M

Sector Composition

Rank Sector Weight
1 Technology 37.9%
2 Healthcare 15.37%
3 Consumer Discretionary 12.43%
4 Communication Services 8.94%
5 Energy 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NET icon
226
Cloudflare
NET
$93B
$1.42M 0.08%
21,731
+1,538
+8% +$91.8K
KRTX
227
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.41M 0.08%
6,480
-1,056
-14% -$226K
MRTX
228
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.4M 0.08%
38,834
+7,307
+23% +$301K
TGTX icon
229
TG Therapeutics
TGTX
$8.58B
$1.4M 0.08%
56,448
-33,956
-38% -$877K
BMRN icon
230
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.4M 0.08%
16,142
+2,478
+18% +$233K
GE icon
231
GE Aerospace
GE
$367B
$1.39M 0.07%
15,874
+1,295
+9% +$105K
AMT icon
232
American Tower
AMT
$77.7B
$1.39M 0.07%
7,170
-128
-2% -$25K
PINS icon
233
Pinterest
PINS
$12.4B
$1.39M 0.07%
50,713
+6,331
+14% +$158K
TVTX icon
234
Travere Therapeutics
TVTX
$5.33B
$1.38M 0.07%
89,930
+29,401
+49% +$535K
ETNB
235
DELISTED
89bio
ETNB
$1.38M 0.07%
72,573
+14,497
+25% +$255K
DNLI icon
236
Denali Therapeutics
DNLI
$3.67B
$1.37M 0.07%
46,475
-2,352
-5% -$66.1K
CVS icon
237
CVS Health
CVS
$137B
$1.37M 0.07%
19,776
+459
+2% +$32.7K
MTCH icon
238
Match Group
MTCH
$8.84B
$1.36M 0.07%
32,508
+3,102
+11% +$113K
MORF
239
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$1.36M 0.07%
23,692
+12,519
+112% +$654K
AKRO
240
DELISTED
Akero Therapeutics
AKRO
$1.35M 0.07%
28,994
-1,584
-5% -$72.6K
CRSP icon
241
CRISPR Therapeutics
CRSP
$4.58B
$1.35M 0.07%
24,084
-4,525
-16% -$257K
GM icon
242
General Motors
GM
$74.7B
$1.35M 0.07%
34,986
+11,547
+49% +$399K
TCOM icon
243
Trip.com Group
TCOM
$27.5B
$1.35M 0.07%
38,510
-3,115
-7% -$108K
MDGL icon
244
Madrigal Pharmaceuticals
MDGL
$12.6B
$1.35M 0.07%
5,825
+459
+9% +$124K
IOVA icon
245
Iovance Biotherapeutics
IOVA
$2.23B
$1.35M 0.07%
191,083
-10,954
-5% -$78.4K
DE icon
246
Deere & Co
DE
$170B
$1.33M 0.07%
3,273
+247
+8% +$94.5K
RARE icon
247
Ultragenyx Pharmaceutical
RARE
$2.65B
$1.32M 0.07%
28,706
-3,195
-10% -$148K
SRPT icon
248
Sarepta Therapeutics
SRPT
$1.66B
$1.32M 0.07%
11,552
+2,960
+34% +$382K
ITUB icon
249
Itaú Unibanco
ITUB
$91.3B
$1.32M 0.07%
253,194
+15,752
+7% +$74.5K
ETSY icon
250
Etsy
ETSY
$7.65B
$1.32M 0.07%
15,555
+3,637
+31% +$343K
8 9
10
11 12

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Profund Advisors held 1,158 positions worth $1.86B, up 15% from $1.62B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Profund Advisors deployed $82.5M of net new capital in Q2 2023, opening 69 new positions and adding to 498 existing holdings. Its largest new stake was Biomea Fusion: 24,713 shares worth $542K.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Fiserv Inc, an estimated $3.11M trimmed.

  • Profund Advisors's largest Q2 2023 buy was Biomea Fusion: 24,713 shares worth $542K.
  • Profund Advisors added most to Apple in Q2 2023, an estimated $12.9M increase.
  • Profund Advisors's biggest Q2 2023 reduction was Fiserv Inc, cutting an estimated $3.11M.
  • Profund Advisors fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $1.23M.
  • Profund Advisors's ten largest holdings make up 34% of its $1.86B portfolio in Q2 2023.
  • Profund Advisors opened 69 new positions and closed 91 in Q2 2023.
  • Profund Advisors's portfolio value rose 15% quarter-over-quarter to $1.86B.

Based on Profund Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.